- 17 years of ownership
- Creation of the world leader in allergen immunotherapy
- Revenue multiplied by 10
- Sale to a family investment company with strong industrial focus (Ares Life Sciences, founded by the Bertarelli family)
- Investment multiple of 35x
- Amount invested by Wendel: €12 million
40 years of sustainable growth
For more than 40 years, Wendel has been a pioneer in the private equity sector. Over the decades, the Group’s teams have made bold investment choices at strategic times. These successes are illustrated by the creation of world leaders specializing in various sectors.